9/9/2008
CVBT Announces First Site to Begin Patient Enrollment for Its Phase II Heart Trial

7/1/2008
Dutton Associates Announces Investment Opinion: CardioVascular BioTherapeutics Maintained At Neutral Rating By Dutton Associates

6/10/2008
CVBT Inks Third Clinical Development Agreement

5/22/2008
Dr. Christopher Moore to Form ProDerm LP to Fund CVBT Wound Healing Trial